StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.28+0.10 (+2.39%)

Close on Nov 18, 2026Market cap $106.09MP/E –Yield –

Lexaria Bioscience market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lexaria Bioscience's market cap was $115.01M on Nov 11, 2026, against $319.78M a year earlier. Over the last 5 years it ranged from $65.19M to $969.91M, with a median of $262.69M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$115.01M-36.5%
2025Dec 31, 2025$181.01M-70.6%
2024Dec 31, 2024$616.08M+306.1%
2023Dec 29, 2023$151.71M-30.9%
2022Dec 30, 2022$219.58M-36.6%
2021Dec 31, 2021$346.16M+2.8%
2020Dec 31, 2020$336.74M-25.5%
2019Dec 31, 2019$452.06M-57.1%
2018Dec 31, 2018$1.05B-38.9%
2017Dec 29, 2017$1.72B+622.5%
2016Dec 30, 2016$238.50M–

More Lexaria Bioscience figures

See a number that looks wrong?